Mark D Zeglis, MD - Medicare Gastroenterology in Ypsilanti, MI

Mark D Zeglis, MD is a medicare enrolled "Internal Medicine - Gastroenterology" physician in Ypsilanti, Michigan. He went to University Of Michigan Homeopathic Medical School and graduated in 2001 and has 23 years of diverse experience with area of expertise as Gastroenterology. He is a member of the group practice Huron Gastroenterology Associates P.c. and his current practice location is 5300 Elliott Dr, Ypsilanti, Michigan. You can reach out to his office (for appointments etc.) via phone at (734) 434-6262.

Mark D Zeglis is licensed to practice in Michigan (license number 4301083313) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1497898233.

Contact Information

Mark D Zeglis, MD
5300 Elliott Dr,
Ypsilanti, MI 48197-8632
(734) 434-6262
(734) 712-2820



Physician's Profile

Full NameMark D Zeglis
GenderMale
SpecialityGastroenterology
Experience23 Years
Location5300 Elliott Dr, Ypsilanti, Michigan
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Mark D Zeglis attended and graduated from University Of Michigan Homeopathic Medical School in 2001
  NPI Data:
  • NPI Number: 1497898233
  • Provider Enumeration Date: 02/14/2007
  • Last Update Date: 01/14/2010
  Medicare PECOS Information:
  • PECOS PAC ID: 3476653858
  • Enrollment ID: I20070713000697

Medical Identifiers

Medical identifiers for Mark D Zeglis such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1497898233NPI-NPPES
0H14989OtherMIBCBS GROUP
5175340MedicaidMI
6U10025OtherMIHAP
P00615775OtherMIMEDICARE RAILROAD PTAN
0814548OtherMIBCBS INDIVIDUAL
7489887OtherMIAETNA
3902640OtherMICIGNA
025100OtherMIMIDWEST HEALTH PLAN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RG0100XInternal Medicine - Gastroenterology 4301083313 (Michigan)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
St Joseph Mercy HospitalAnn arbor, MIHospital
St Joseph Mercy ChelseaChelsea, MIHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Huron Gastroenterology Associates P.c.084028822165

News Archive

Oraya awarded NIH grant to study how gold nanoparticles can enhance Wet AMD treatment

Oraya Therapeutics, Inc. announced today that they have been awarded a $215,000 Small Business Technology Transfer Grant from the National Institutes of Health to investigate how Oraya Therapy, a low voltage stereotactic radiotherapy, and gold nanoparticles can further enhance the treatment of wet age-related macular degeneration (Wet AMD).

Scientists identify specific mechanisms by which vitamin D inhibits inflammation

Researchers at National Jewish Health have discovered specific molecular and signaling events by which vitamin D inhibits inflammation. In their experiments, they showed that low levels of Vitamin D, comparable to levels found in millions of people, failed to inhibit the inflammatory cascade, while levels considered adequate did inhibit inflammatory signaling.

Lansoprazole does not control asthma in children

Asthma and gastroesophageal reflux (GER) are both common illnesses in children. GER in children often occurs without the typical symptoms of heartburn, and physicians frequently prescribe the acid reflux drug lansoprazole to supplement the standard inhaled steroid treatment for children with uncontrolled asthma regardless of GER symptoms.

Renowned diabetologists and healthcare professionals attend International Abu Dhabi Diabetes Congress

The 1st International Abu Dhabi Diabetes Congress kicked off today with over 500 of the leading diabetologists and healthcare professionals from around the world in attendance.

Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin proteins to treat cancer and fibrosis, today announced that the Japan Patent Office has accepted a new patent, No. 2002-574987, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer". The patent protects, among other things, methods for reducing the toxicity of chemotherapies in which a polysaccharide, such as the Company's lead drug DAVANAT®, is co-administered with a chemotherapeutic agent to reduce toxicity of the chemotherapy.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mark D Zeglis allows following entities to bill medicare on his behalf.
Entity NameHuron Gastroenterology Associates P.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144335639
PECOS PAC ID: 0840288221
Enrollment ID: O20040504001055

News Archive

Oraya awarded NIH grant to study how gold nanoparticles can enhance Wet AMD treatment

Oraya Therapeutics, Inc. announced today that they have been awarded a $215,000 Small Business Technology Transfer Grant from the National Institutes of Health to investigate how Oraya Therapy, a low voltage stereotactic radiotherapy, and gold nanoparticles can further enhance the treatment of wet age-related macular degeneration (Wet AMD).

Scientists identify specific mechanisms by which vitamin D inhibits inflammation

Researchers at National Jewish Health have discovered specific molecular and signaling events by which vitamin D inhibits inflammation. In their experiments, they showed that low levels of Vitamin D, comparable to levels found in millions of people, failed to inhibit the inflammatory cascade, while levels considered adequate did inhibit inflammatory signaling.

Lansoprazole does not control asthma in children

Asthma and gastroesophageal reflux (GER) are both common illnesses in children. GER in children often occurs without the typical symptoms of heartburn, and physicians frequently prescribe the acid reflux drug lansoprazole to supplement the standard inhaled steroid treatment for children with uncontrolled asthma regardless of GER symptoms.

Renowned diabetologists and healthcare professionals attend International Abu Dhabi Diabetes Congress

The 1st International Abu Dhabi Diabetes Congress kicked off today with over 500 of the leading diabetologists and healthcare professionals from around the world in attendance.

Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin proteins to treat cancer and fibrosis, today announced that the Japan Patent Office has accepted a new patent, No. 2002-574987, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer". The patent protects, among other things, methods for reducing the toxicity of chemotherapies in which a polysaccharide, such as the Company's lead drug DAVANAT®, is co-administered with a chemotherapeutic agent to reduce toxicity of the chemotherapy.

Read more Medical News

› Verified 9 days ago

Entity NameSt Mary Mercy Hospital Professional
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1528145554
PECOS PAC ID: 2365521226
Enrollment ID: O20080502000426

News Archive

Oraya awarded NIH grant to study how gold nanoparticles can enhance Wet AMD treatment

Oraya Therapeutics, Inc. announced today that they have been awarded a $215,000 Small Business Technology Transfer Grant from the National Institutes of Health to investigate how Oraya Therapy, a low voltage stereotactic radiotherapy, and gold nanoparticles can further enhance the treatment of wet age-related macular degeneration (Wet AMD).

Scientists identify specific mechanisms by which vitamin D inhibits inflammation

Researchers at National Jewish Health have discovered specific molecular and signaling events by which vitamin D inhibits inflammation. In their experiments, they showed that low levels of Vitamin D, comparable to levels found in millions of people, failed to inhibit the inflammatory cascade, while levels considered adequate did inhibit inflammatory signaling.

Lansoprazole does not control asthma in children

Asthma and gastroesophageal reflux (GER) are both common illnesses in children. GER in children often occurs without the typical symptoms of heartburn, and physicians frequently prescribe the acid reflux drug lansoprazole to supplement the standard inhaled steroid treatment for children with uncontrolled asthma regardless of GER symptoms.

Renowned diabetologists and healthcare professionals attend International Abu Dhabi Diabetes Congress

The 1st International Abu Dhabi Diabetes Congress kicked off today with over 500 of the leading diabetologists and healthcare professionals from around the world in attendance.

Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin proteins to treat cancer and fibrosis, today announced that the Japan Patent Office has accepted a new patent, No. 2002-574987, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer". The patent protects, among other things, methods for reducing the toxicity of chemotherapies in which a polysaccharide, such as the Company's lead drug DAVANAT®, is co-administered with a chemotherapeutic agent to reduce toxicity of the chemotherapy.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mark D Zeglis is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mark D Zeglis, MD
5300 Elliott Dr,
Ypsilanti, MI 48197-8632

Ph: (734) 434-6262
Mark D Zeglis, MD
5300 Elliott Dr,
Ypsilanti, MI 48197-8632

Ph: (734) 434-6262

News Archive

Oraya awarded NIH grant to study how gold nanoparticles can enhance Wet AMD treatment

Oraya Therapeutics, Inc. announced today that they have been awarded a $215,000 Small Business Technology Transfer Grant from the National Institutes of Health to investigate how Oraya Therapy, a low voltage stereotactic radiotherapy, and gold nanoparticles can further enhance the treatment of wet age-related macular degeneration (Wet AMD).

Scientists identify specific mechanisms by which vitamin D inhibits inflammation

Researchers at National Jewish Health have discovered specific molecular and signaling events by which vitamin D inhibits inflammation. In their experiments, they showed that low levels of Vitamin D, comparable to levels found in millions of people, failed to inhibit the inflammatory cascade, while levels considered adequate did inhibit inflammatory signaling.

Lansoprazole does not control asthma in children

Asthma and gastroesophageal reflux (GER) are both common illnesses in children. GER in children often occurs without the typical symptoms of heartburn, and physicians frequently prescribe the acid reflux drug lansoprazole to supplement the standard inhaled steroid treatment for children with uncontrolled asthma regardless of GER symptoms.

Renowned diabetologists and healthcare professionals attend International Abu Dhabi Diabetes Congress

The 1st International Abu Dhabi Diabetes Congress kicked off today with over 500 of the leading diabetologists and healthcare professionals from around the world in attendance.

Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan

Pro-Pharmaceuticals, Inc., the leading developer of therapeutics that target Galectin proteins to treat cancer and fibrosis, today announced that the Japan Patent Office has accepted a new patent, No. 2002-574987, "Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer". The patent protects, among other things, methods for reducing the toxicity of chemotherapies in which a polysaccharide, such as the Company's lead drug DAVANAT®, is co-administered with a chemotherapeutic agent to reduce toxicity of the chemotherapy.

Read more News

› Verified 9 days ago


Internal Medicine Doctors in Ypsilanti, MI

Bretton Lee Schloesser, M.D.
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197
Phone: 734-712-8676    
Dr. Kelly Perry Apple, M.D.
Gastroenterology
Medicare: Medicare Enrolled
Practice Location: 5301 E Huron River Dr, Ypsilanti, MI 48197
Phone: 734-712-8676    Fax: 734-712-3855
Rajiv Doddamani,
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 5333 Mcauley Dr, Suite 4001, Ypsilanti, MI 48197
Phone: 734-834-4270    
Dr. James Paolo Purtell, MD
Gastroenterology
Medicare: Medicare Enrolled
Practice Location: 5333 Mcauley Dr, Suite 2111, Ypsilanti, MI 48197
Phone: 734-712-5552    
Kory Ashton Strong, DO
Gastroenterology
Medicare: Medicare Enrolled
Practice Location: Iha Hospital Medicine Services, 5301 E Huron River Drive, Ypsilanti, MI 48197
Phone: 734-712-8676    
Michael Sanson, M.D.
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 5361 Mcauley Dr, Ypsilanti, MI 48197
Phone: 734-712-1300    Fax: 734-222-3665
Dr. Stephanie Joy-kraftson Hoffman, MD
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: Iha Hematology Oncology, 5303 Elliott Drive, Suite 210, Ypsilanti, MI 48197
Phone: 734-712-1000    Fax: 734-712-1012

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.